information meeting february 2003 1 s anof i y nt h é la b o f ebr uary 200 3 2 this release contains statements that constitute forward looking within the meaning of us private securities litigation reform act 1995 these are based on management current expectations or beliefs and subject to a number factors uncertainties could cause actual results differ materially from those described in following among others ability sanofi synthélabo expand its presence profitably united states success research development programs protect intellectual property rights risks associated with reimbursement health care costs pricing reforms particularly france investors security holders may obtain free copy documents filed by exchange commission at www sec gov directly
